TECH

Q: What is the price of Bio-Techne (TECH) today?

The price of Bio-Techne (TECH) today is $ 57.82, with return of -5.82% compared to the last year. The price of Bio-Techne (TECH) started the year trading around $ 58.81 and today it is at $ 57.82. Follow the real-time price chart, the historical price of Bio-Techne (TECH) and international markets.

Q: When does Bio-Techne (TECH) pay dividends?

In the last year, Bio-Techne (TECH) distributed dividends in the month of February, totaling $ 0.08. The Dividend Yield for the last 12 months is 0.54%.

Q: Is Bio-Techne (TECH) worth it?

Currently, Bio-Techne (TECH) is priced at $ 57.82, with a P/E of 113.48%, representing a deviation of 7,252% from its historical average P/E. In the last year, the stock showed a variation of -5.82 in its price and distributed $ 0.08 in dividends, resulting in a Dividend Yield of 0.54%. The total shareholder return was -5.82%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Bio-Techne (TECH) stock?

Investing in stocks of Bio-Techne (TECH) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Bio-Techne (TECH) yield today?

The yield of Bio-Techne (TECH) was -9.66% in the last month, -5.82% in the last year and -32.09% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.32 in dividends, with a Dividend Yield of 0.54%.If you wanted to buy 100 stocks of Bio-Techne (TECH) today, the total investment would be $ 5,782.00, based on the current price of $ 57.82.If past performance were to repeat, the return on your investment would be:In 1 year: $ 5,445.49In 5 years: $ 3,926.56In 10 years: $ 15,254.65It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Bio-Techne Corporation

Price

$ 57.82

return (12m)

-5.82%

p/e

113.48

p/b

4.58

DIVIDEND YIELD

0.54%

price TECH

TECH

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of TECH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-9.66%

3 months

-8.03%

1 year

-5.82%

2 years

-21.47%

5 years

-32.09%

10 years

163.83%

Fundamentals TECH

review the fundamentals of Bio-Techne shares

P/E

113.48

Sector: -3.72 Industry: -3.72

P/S (Price-to-Sales)

7.57

Sector: -3.83 Industry: -3.83

P/B

4.58

Sector: 1.99 Industry: 1.99

DIVIDEND YIELD (DY)

0.54%

Sector: - Industry: -

ROA

3.22%

Sector: -64.61% Industry: -64.61%

ROE

4.03%

Sector: -66.34% Industry: -66.34%

ROIC

7.18%

Sector: -1,293.53% Industry: -1,293.53%

NET MARGIN

6.67%

Sector: -40.94% Industry: -40.94%

GROSS MARGIN

65.22%

Sector: 39.00% Industry: 39.00%

OPERATING MARGIN

9.62%

Sector: -40.81% Industry: -40.81%

EV/EBITDA

41.37

Sector: -3.76 Industry: -3.76

EV/EBIT

77.51

Sector: -3.91 Industry: -3.91

PRICE-TO-ASSETS

3.65

Sector: 1.45 Industry: 1.45

BVPS

12.89

Sector: 1.76 Industry: 1.76

EPS

0.52

Sector: -2.03 Industry: -2.03

EQUITY-TO-ASSETS RATIO

0.80

Sector: 0.40 Industry: 0.40

LIABILITIES / ASSETS

0.20

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

3.38%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-17.37%

Sector: - Industry: -

FAIR VALUE OF Bio-Techne ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 57.82

Fair Value

$ 0.00

Upside Return potential.

-78.76%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals TECH

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/b	ROE	dy	market cap	net margin
JNJ	22.33	7.55	33.81%	2.07%	$ 598.47 B	28.46%
PFE	20.23	1.69	8.35%	6.22%	$ 157.22 B	12.42%
ABBV	97.04	0.00	0.00%	2.87%	$ 410.09 B	6.91%
NVO	10.62	5.47	51.50%	4.51%	$ 166.32 B	33.05%
MRK	16.84	0.00	0.00%	2.65%	$ 307.32 B	28.08%
AZN	31.62	6.64	20.99%	1.50%	$ 323.31 B	17.41%
GILD	21.74	8.18	37.62%	2.12%	$ 185.00 B	28.90%
BMY	18.00	-3.73	-20.72%	3.99%	$ 126.99 B	14.64%
ZTS	21.48	17.24	80.25%	1.53%	$ 57.42 B	28.23%
REGN	17.87	2.58	14.41%	0.45%	$ 80.51 B	31.41%
HALO	25.89	168.09	649.21%	0.00%	$ 8.20 B	22.69%
AMGN	27.13	24.16	89.06%	2.45%	$ 209.22 B	20.98%
MCK	27.98	-1,226.73	-4,383.84%	0.31%	$ 121.45 B	1.09%
VRTX	31.92	6.76	21.18%	0.00%	$ 126.19 B	32.94%
CAH	32.55	-20.04	-61.56%	0.89%	$ 54.10 B	0.68%
ADMA	17.77	8.63	48.57%	0.00%	$ 3.72 B	42.87%
BIIB	21.81	1.54	7.08%	0.00%	$ 28.20 B	13.07%
HRMY	8.91	1.98	22.24%	0.00%	$ 1.66 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

TECH Historical Dividends

current DY: 0.54%

5-year average DY: 0.41%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	02/16/2026	02/27/2026	0,08000000
Dividend	11/17/2025	11/28/2025	0,08000000
Dividend	08/18/2025	08/29/2025	0,08000000
Dividend	05/19/2025	05/30/2025	0,08000000
Dividend	02/17/2025	02/28/2025	0,08000000
Dividend	11/11/2024	11/22/2024	0,08000000
Dividend	08/19/2024	08/30/2024	0,08000000
Dividend	05/13/2024	05/24/2024	0,08000000
Dividend	02/12/2024	02/26/2024	0,08000000
Dividend	11/10/2023	11/24/2023	0,08000000
Dividend	08/18/2023	09/01/2023	0,08000000
Dividend	05/15/2023	05/26/2023	0,08000000
Dividend	02/13/2023	02/27/2023	0,08000000
Dividend	11/14/2022	11/28/2022	0,08000000
Dividend	08/15/2022	08/29/2022	0,08000000
Dividend	05/16/2022	05/27/2022	0,08000000
Dividend	02/11/2022	02/25/2022	0,08000000
Dividend	11/12/2021	11/26/2021	0,08000000
Dividend	08/16/2021	08/27/2021	0,08000000
Dividend	05/17/2021	05/28/2021	0,08000000
Dividend	02/12/2021	02/26/2021	0,08000000
Dividend	11/16/2020	11/27/2020	0,08000000
Dividend	08/18/2020	08/28/2020	0,08000000
Dividend	05/11/2020	05/22/2020	0,08000000
Dividend	02/14/2020	02/28/2020	0,08000000
Dividend	11/08/2019	11/22/2019	0,08000000
Dividend	08/16/2019	08/30/2019	0,08000000
Dividend	05/10/2019	05/24/2019	0,08000000
Dividend	02/15/2019	03/01/2019	0,08000000
Dividend	11/09/2018	11/23/2018	0,08000000
Dividend	08/17/2018	08/31/2018	0,08000000
Dividend	05/14/2018	05/25/2018	0,08000000
Dividend	02/16/2018	03/02/2018	0,08000000
Dividend	11/10/2017	11/24/2017	0,08000000
Dividend	08/18/2017	09/01/2017	0,08000000
Dividend	05/19/2017	06/02/2017	0,08000000
Dividend	02/17/2017	03/03/2017	0,08000000
Dividend	11/14/2016	11/28/2016	0,08000000
Dividend	08/29/2016	09/12/2016	0,08000000
Dividend	05/13/2016	05/27/2016	0,08000000
Dividend	02/12/2016	02/26/2016	0,08000000
Dividend	11/13/2015	11/27/2015	0,08000000
Dividend	08/17/2015	08/28/2015	0,08000000
Dividend	05/15/2015	05/29/2015	0,08000000
Dividend	02/13/2015	02/27/2015	0,08000000
Dividend	11/10/2014	11/24/2014	0,08000000
Dividend	08/21/2014	08/29/2014	0,07750000
Dividend	05/09/2014	05/23/2014	0,07750000
Dividend	02/14/2014	02/28/2014	0,07750000
Dividend	11/12/2013	11/25/2013	0,07750000
Dividend	08/16/2013	08/30/2013	0,07500000
Dividend	05/10/2013	05/24/2013	0,07500000
Dividend	02/15/2013	03/01/2013	0,07500000
Dividend	11/05/2012	11/19/2012	0,07500000
Dividend	08/10/2012	08/24/2012	0,07000000
Dividend	05/11/2012	05/25/2012	0,07000000
Dividend	02/10/2012	02/24/2012	0,07000000
Dividend	11/07/2011	11/21/2011	0,07000000
Dividend	08/12/2011	08/26/2011	0,06750000
Dividend	05/13/2011	05/27/2011	0,06750000
Dividend	02/11/2011	02/28/2011	0,06750000
Dividend	11/08/2010	11/22/2010	0,06750000
Dividend	08/16/2010	08/31/2010	0,06500000
Dividend	05/14/2010	05/28/2010	0,06500000
Dividend	02/12/2010	02/26/2010	0,06500000
Dividend	11/09/2009	11/23/2009	0,06500000
Dividend	08/17/2009	08/31/2009	0,06250000
Dividend	05/08/2009	05/22/2009	0,06250000
Dividend	02/13/2009	02/27/2009	0,06250000
Dividend	11/03/2008	11/17/2008	0,06250000

ABOUT THE COMPANY Bio-Techne

Bio-Techne Corporation

Average user rating I10

4.0 (2 people)

United States

50 years

Founded: 1976

1992

Time since IPO - 34 years

2.300

Employees

The Company Bio-Techne Corporation (United States), is listed on Nasdaq with a market value of $ 9.20 Billions, having an equity of $ 2.01 Billions.

With a total of 2.300 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 1.22 Billion, which generated a profit in the amount of $ 81.11 Millions.

As for its main indicators, the Company has a P/E ratio of 113.48, a P/BV ratio of 4.58 and in the last 12 months the dividend yield of TECH was at 0.54%.

The Company is traded internationally through the ticker TECH.

Market cap

$ 9.20 Billions

Net worth

$ 2.01 Billions

US$ 2,010,990,000.00

Assets

$ 2.52 Billions

US$ 2,522,700,000.00

Total Shares Outstanding

156.00 Millions

156,000,000

Average Daily Trading Volume

$ 2.27 Millions

US$ 2,265,934.50

Sector

Health Care

Industry

Biotechnology

TECH

TECH revenue and profits

Financial Results TECH

DRAG THE FRAME TO SEE MORE DATA

TECH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/B

0.00

MCK - McKesson

$ 990.95 54,53% (12M)

P/E

27.98

0.31%

ROE

-4,383.84%

P/B

-1,226.73

CAH - Cardinal Health

$ 229.88 80,59% (12M)

P/E

32.55

0.89%

ROE

-61.56%

P/B

-20.04

JNJ - Johnson & Johnson

$ 248.56 52,73% (12M)

P/E

22.33

2.07%

ROE

33.81%

P/B

7.55

PFE - Pfizer

$ 27.26 13,23% (12M)

P/E

20.23

6.22%

ROE

8.35%

P/B

1.69

ABBV - AbbVie

$ 234.26 15,35% (12M)

P/E

97.04

2.87%

ROE

0.00%

P/B

0.00

MRK - Merck & Co.

$ 121.41 36,18% (12M)

P/E

16.84

2.65%

ROE

0.00%

P/B

0.00

AZN - AstraZeneca

$ 203.73 38,15% (12M)

P/E

31.62

1.50%

ROE

20.99%

P/B

6.64

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 990.95 54,53% (12 M)

P/L

27.98

0.31%

ROE

-4,383.84%

P/VP

-1,226.73

CAH - Cardinal Health

$ 229.88 80,59% (12 M)

P/L

32.55

0.89%

ROE

-61.56%

P/VP

-20.04

JNJ - Johnson & Johnson

$ 248.56 52,73% (12 M)

P/L

22.33

2.07%

ROE

33.81%

P/VP

7.55

PFE - Pfizer

$ 27.26 13,23% (12 M)

P/L

20.23

6.22%

ROE

8.35%

P/VP

1.69

ABBV - AbbVie

$ 234.26 15,35% (12 M)

P/L

97.04

2.87%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 121.41 36,18% (12 M)

P/L

16.84

2.65%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 203.73 38,15% (12 M)

P/L

31.62

1.50%

ROE

20.99%

P/VP

6.64

Frequently Asked Questions

What is the price of Bio-Techne (TECH) today?

The price of Bio-Techne (TECH) today is $ 57.82, with return of -5.82% compared to the last year. The price of Bio-Techne (TECH) started the year trading around $ 58.81 and today it is at $ 57.82. Follow the real-time price chart, the historical price of Bio-Techne (TECH) and international markets.

When does Bio-Techne (TECH) pay dividends?

In the last year, Bio-Techne (TECH) distributed dividends in the month of February, totaling $ 0.08. The Dividend Yield for the last 12 months is 0.54%.

Is Bio-Techne (TECH) worth it?

Currently, Bio-Techne (TECH) is priced at $ 57.82, with a P/E of 113.48%, representing a deviation of 7,252% from its historical average P/E. In the last year, the stock showed a variation of -5.82 in its price and distributed $ 0.08 in dividends, resulting in a Dividend Yield of 0.54%. The total shareholder return was -5.82%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Bio-Techne (TECH) stock?

Investing in stocks of Bio-Techne (TECH) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Bio-Techne (TECH) yield today?

The yield of Bio-Techne (TECH) was -9.66% in the last month, -5.82% in the last year and -32.09% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.32 in dividends, with a Dividend Yield of 0.54%.

If you wanted to buy 100 stocks of Bio-Techne (TECH) today, the total investment would be $ 5,782.00, based on the current price of $ 57.82.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 5,445.49
In 5 years: $ 3,926.56
In 10 years: $ 15,254.65

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

TECH

Bio-Techne Corporation

Price

return (12m)

p/e

p/b

DIVIDEND YIELD

Return of TECH

review the fundamentals of Bio-Techne shares

P/E

P/S (Price-to-Sales)

P/B

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.54%

5-year average DY: 0.41%

type

Ex - Dividend Date

payment date

value

ABOUT THE COMPANY Bio-Techne

Bio-Techne Corporation

United States

50 years

1992

2.300

PROFIT X PRICE TECH

Financial Results TECH

TECH cash flow

asset growth - TECH

TECH balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions